Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel? Ramaswamy V, Bartels U. Neuro Oncol 2021 Jul 12. pii: 6319139. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramaswamy V, Bartels U. Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel? Neuro Oncol 2021 Jul 12. pii: 6319139. doi: 10.1093.
PMID: 34251024